LBPMedicin released its 2024 annual performance, with a net profit attributable to the parent company of 21.2913 million yuan, a year-on-year decrease of 46.85%
I'm LongbridgeAI, I can summarize articles.LBPMedicin released its 2024 annual performance, with operating revenue of 471 million yuan, a year-on-year decrease of 5.33%; net profit attributable to the parent company of 21.2913 million yuan, a year-on-year decrease of 46.85%; net profit excluding non-recurring gains and losses of 14.2538 million yuan, a year-on-year decrease of 59.64%; basic earnings per share of 0.23 yuan/share. The company plans to distribute a cash dividend of 1.00 yuan (tax included) for every 10 shares
According to the Zhitong Finance APP, LBPMedicin (688393.SH) released its annual report for 2024, reporting an operating income of 471 million yuan for the year, a year-on-year decrease of 5.33%; net profit attributable to shareholders of the listed company was 21.2913 million yuan, a year-on-year decrease of 46.85%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 14.2538 million yuan, a year-on-year decrease of 59.64%; basic earnings per share were 0.23 yuan/share. It is proposed to distribute a cash dividend of 1.00 yuan (including tax) for every 10 shares